ZA911956B - 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances - Google Patents

9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances

Info

Publication number
ZA911956B
ZA911956B ZA911956A ZA911956A ZA911956B ZA 911956 B ZA911956 B ZA 911956B ZA 911956 A ZA911956 A ZA 911956A ZA 911956 A ZA911956 A ZA 911956A ZA 911956 B ZA911956 B ZA 911956B
Authority
ZA
South Africa
Prior art keywords
clathrates
chlor
prostaglandin
cyclodextrin
beta
Prior art date
Application number
ZA911956A
Inventor
Bernd Buchmann
Buchmann Bernd
Werner Skuballa
Skuballa Werner
Helmut Vorbruggen
Vorbruggen Helmut
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA911956B publication Critical patent/ZA911956B/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
ZA911956A 1990-03-16 1991-03-15 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances ZA911956B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4008925A DE4008925A1 (en) 1990-03-16 1990-03-16 New clathrates of 9-chloro-prostaglandin(s) with beta-cyclodextrin

Publications (1)

Publication Number Publication Date
ZA911956B true ZA911956B (en) 1991-12-24

Family

ID=6402643

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA911956A ZA911956B (en) 1990-03-16 1991-03-15 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances

Country Status (7)

Country Link
EP (1) EP0447015A1 (en)
AU (1) AU7499091A (en)
DE (1) DE4008925A1 (en)
IE (1) IE910901A1 (en)
PT (1) PT97067A (en)
WO (1) WO1991013634A1 (en)
ZA (1) ZA911956B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4229050A1 (en) * 1992-08-31 1994-03-03 Schering Ag New esters and amides of 9-chloro-prostaglandins - useful, e.g., in treatment of glaucoma and as diuretic agents
DE59308617D1 (en) * 1992-08-31 1998-07-02 Schering Ag 9-CHLORINE PROSTAGLANDIN ESTERS AND AMIDES AND THEIR USE FOR THE PRODUCTION OF MEDICINAL PRODUCTS
NZ330596A (en) * 1998-06-05 2001-02-23 Dec Res Intravaginal devices allowing for increased uptake of active ingredients
FR2799376B1 (en) 1999-10-07 2002-01-18 Marc Brunel SINGLE USE INJECTION DEVICE
FR2971424B1 (en) 2011-02-14 2013-11-29 Marc Brunel SAFETY SYRINGE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3504044A1 (en) * 1985-02-04 1986-08-07 Schering AG, Berlin und Bergkamen, 1000 Berlin 9-HALOGEN PROSTAGLANDIN CLATHRATE AND THEIR USE AS A MEDICINAL PRODUCT
EP0299914B2 (en) * 1987-07-17 2003-04-23 Schering Aktiengesellschaft 9-Halogen (Z) prostaglandin derivatives, process for their production and their use as medicines

Also Published As

Publication number Publication date
PT97067A (en) 1991-10-31
WO1991013634A1 (en) 1991-09-19
DE4008925A1 (en) 1991-09-19
EP0447015A1 (en) 1991-09-18
IE910901A1 (en) 1991-09-25
AU7499091A (en) 1991-10-10

Similar Documents

Publication Publication Date Title
EP0475434A3 (en) Polymer composition and its use
EP0498268A3 (en) 5-oxo-l-proline derivatives and pharmaceutical use thereof
ZA929127B (en) Quinoline-3-carboxamides their manufacture and use
EP0304802A3 (en) Pharmaceutical composition and the use thereof
IL97122A0 (en) Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them
EP0482649A3 (en) Cm-chitin derivatives and use thereof
ZA929128B (en) Hydroxypyridonecarboxamides their manufacture and use
ZA903409B (en) Maleinimide-derivatives and their use as pharmaceuticals
GB8919726D0 (en) Ws7338 substances and preparation thereof
EP0465132A3 (en) Dna and its use
GB9027864D0 (en) Pyrimidinyl-and triazinyl-salicylamides and their use and preparation
ZA911956B (en) 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances
ZA911065B (en) Chemical and pharmaceutical compositions
HU9204072D0 (en) Terazole derivatives and medical preparatives containing them
ZA959904B (en) Iminooxymethyleneanilides thei preparation and their use
GB9016027D0 (en) Composition and use
IL97366A (en) Aryl-propyl-amines their preparation and their use as fungicides
IL114161A0 (en) Amido- quinoxalinediones pharmaceutical compositions containing them and their use
IL105873A0 (en) Pyrimidinyl-and triazinyl-salicyl-and-picolyl-amides and the use and preparation thereof
ZA935119B (en) Medicinal composition comprising TCF-II
GB9000241D0 (en) Pharmaceutical use
HU9203050D0 (en) Thieno-cyclopentanole-oximes and pharmaceutical preparatives containing them
ZA942246B (en) Novel imidazolo-quinoxalinones their preparation and use
ZA928419B (en) Pharmaceutical substances or compositions and their use
GB9001318D0 (en) Wb968 substances and preparation thereof